These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8504051)

  • 1. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
    Langner A; Verjans H; Stapór V; Mol M; Fraczykowska M
    Br J Dermatol; 1993 May; 128(5):566-71. PubMed ID: 8504051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A; Ashton P; Van De Kerkhof PC; Verjans H
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
    Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
    Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
    Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
    Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of topical calcitriol 3 microg g(-1) ointment.
    Gerritsen MJ; Van De Kerkhof PC; Langner A
    Br J Dermatol; 2001 Apr; 144 Suppl 58():17-9. PubMed ID: 11501508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
    Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
    Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
    Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
    Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis.
    Barker JN; Berth-Jones J; Groves R; Omerod AD; Rizova E; Griffiths CE
    J Dermatolog Treat; 2003 Jan; 14(1):14-21. PubMed ID: 12745850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland.
    Langner A; Stapór W; Ambroziak M
    Br J Dermatol; 2001 Apr; 144 Suppl 58():11-6. PubMed ID: 11501507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
    Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
    Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.
    Pèrez A; Chen TC; Turner A; Raab R; Bhawan J; Poche P; Holick MF
    Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
    Feldman SR; Mills M; Brundage T; Eastman WJ
    J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study.
    Carboni I; de Felice C; Bergamin A; Chimenti S
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():11-3. PubMed ID: 16274406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind comparison of the effects on systemic calcium homeostasis of topical calcitriol (3 micrograms/g) and calcipotriol (50 micrograms/g) in the treatment of chronic plaque psoriasis vulgaris.
    Bourke JF; Iqbal SJ; Hutchinson PE
    Acta Derm Venereol; 1997 May; 77(3):228-30. PubMed ID: 9188878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.